Ua hoʻolaha ka World Health Organization (WHO) i kēia lā e hōʻano hou ana ʻo GlaxoSmithKline (GSK) i kāna kūpaʻa e hāʻawi i ka lāʻau deworming albendazole a hiki i ka hoʻopau ʻana o ka lymphatic filariasis ma ke ʻano he pilikia olakino. Eia kekahi, ma ka 2025, e hāʻawi ʻia nā 200 miliona papa i kēlā me kēia makahiki no ka mālama ʻana iā STH, a ma ka 2025, 5 miliona mau papa i kēlā me kēia makahiki no ka mālama ʻana i ka cystic echinococcosis.
Hoʻokumu ʻia kēia hoʻolaha hou ma luna o ka hoʻokō 23 makahiki o ka hui e hakakā i ʻekolu Neglected Tropical Diseases (NTDs) e lawe nui nei i kekahi o nā kaiāulu ʻilihune o ka honua.
ʻO kēia mau ʻōlelo hoʻohiki he ʻāpana wale nō ia o ka manaʻo nui i hana ʻia e GSK i kēia lā ma ka Malaria and Neglected Tropical Diseases Summit ma Kigali, kahi i hoʻolaha ai lākou i kahi kālā £1 biliona ma mua o 10 mau makahiki e hoʻolalelale i ka holomua o nā maʻi maʻi. - nā ʻāina o ka loaʻa kālā. Hoʻopuka paʻi).
E kālele ana ka noiʻi i nā lāʻau lapaʻau hou a me nā lāʻau lapaʻau no ka pale ʻana a me ka mālama ʻana i ka maʻi maʻi, maʻi maʻi, HIV (ma o ViiV Healthcare) a me ka mālama ʻole ʻia ʻana o nā maʻi tropical, a me ka hoʻoponopono ʻana i ka kūʻē antimicrobial, e hoʻomau nei i ka hoʻopilikia ʻana i ka poʻe nāwaliwali loa a ke kumu o ka make. . ʻO ke kaumaha o ka maʻi ma nā ʻāina haʻahaʻa haʻahaʻa ma mua o 60%.